Key result
A new duplex RT-qPCR detected human norovirus in 100% of 23 positive clinical samples compared to 82.6% with the standard Kageyama RT-qPCR assay.
Why the study?
Widely used HuNoV RT-qPCR primers and probes established in the early 2000s work less efficiently over time due to viral genome mutations.
Does ND-RT-qPCR improve detection sensitivity of GI and GII Human Noroviruses compared to Kageyama RT-qPCR in clinical samples?
Does ND-RT-qPCR improve detection sensitivity of GI and GII Human Noroviruses compared to Kageyama RT-qPCR in clinical samples?
The redesigned duplex RT-qPCR provides higher sensitivity for detecting current strains of GI and GII human noroviruses compared to older standard assays.
Answers are grounded in this paper and cite their sources.
May improve norovirus detection in clinical samples; leaves open routine adoption pending larger validation studies.
Human noroviruses (HuNoVs) are major foodborne pathogens that cause nonbacterial acute gastroenteritis worldwide. As the tissue-culture system for HuNoVs is not mature enough for routine detection of the virus, detection is mainly dependent on molecular approaches such as reverse transcription polymerase chain reaction (RT-PCR) and reverse transcription quantitative real-time polymerase chain reaction (RT-qPCR). The widely used primers and probes for RT-qPCR were established in the early 2000s. As HuNoVs are highly variant viruses, viral genome mutations result in previously designed primers and/or probes that were perfectly matched working less efficiently over time. In this study, a new duplex RT-qPCR (ND-RT-qPCR) was designed for the detection of genogroup I (GI) and genogroup II (GII) HuNoVs based on an analysis of viral sequences added in the database after 2010. Using long transcribed viral RNAs, the results demonstrate that the sensitivity of ND-RT-qPCR is as low as one genomic copy for both GI and GII HuNoVs. The performance of ND-RT-qPCR was further evaluated by a comparison with the commonly used Kageyama primer/probe sets for RT-qPCR (Kageyama RT-qPCR) for 23 HuNoV-positive clinical samples. All five GI samples were registered as positive by ND-RT-qPCR, whereas only two samples were registered as positive by Kageyama RT-qPCR. All 18 GII samples were registered as positive by ND-RT-qPCR, while 17 samples were registered as positive by Kageyama RT-qPCR. The sensitivity reflected by the quantification cycle (Cq) value was lower in ND-RT-qPCR than in Kageyama RT-qPCR. Our data suggest that ND-RT-qPCR could be a good fit for the detection of current strains of HuNoVs.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2020) studied Human norovirus infection (n=23). New duplex RT-qPCR (ND-RT-qPCR) vs. Kageyama RT-qPCR was evaluated on Detection of human norovirus (positivity rate). A new duplex RT-qPCR detected human norovirus in 100% of 23 positive clinical samples compared to 82.6% with the standard Kageyama RT-qPCR assay.
Synapse has enriched 10 related papers. Consider them for comparative context: